292 related articles for article (PubMed ID: 18092345)
1. Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease.
Stronati L; Negroni A; Merola P; Pannone V; Borrelli O; Cirulli M; Annese V; Cucchiara S
Inflamm Bowel Dis; 2008 Mar; 14(3):295-302. PubMed ID: 18092345
[TBL] [Abstract][Full Text] [Related]
2. Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.
Negroni A; Stronati L; Pierdomenico M; Tirindelli D; Di Nardo G; Mancini V; Maiella G; Cucchiara S
Inflamm Bowel Dis; 2009 Aug; 15(8):1145-54. PubMed ID: 19266573
[TBL] [Abstract][Full Text] [Related]
3. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
[TBL] [Abstract][Full Text] [Related]
4. NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease.
Pierdomenico M; Cesi V; Cucchiara S; Vitali R; Prete E; Costanzo M; Aloi M; Oliva S; Stronati L
Inflamm Bowel Dis; 2016 Feb; 22(2):315-26. PubMed ID: 26752466
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment.
Guidi L; Costanzo M; Ciarniello M; De Vitis I; Pioli C; Gatta L; Pace L; Tricerri A; Bartoloni C; Coppola L; Balistreri P; Doria G; Fedeli G; Gasbarrini GB
Int J Immunopathol Pharmacol; 2005; 18(1):155-64. PubMed ID: 15698520
[TBL] [Abstract][Full Text] [Related]
7. Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis.
Gan HT; Chen YQ; Ouyang Q
J Gastroenterol Hepatol; 2005 Jul; 20(7):1016-24. PubMed ID: 15955209
[TBL] [Abstract][Full Text] [Related]
8. Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFalpha polymorphisms.
Linderson Y; Bresso F; Buentke E; Pettersson S; D'Amato M
Int J Colorectal Dis; 2005 Jul; 20(4):305-11. PubMed ID: 15800781
[TBL] [Abstract][Full Text] [Related]
9. NOD2/CARD15 does not influence response to infliximab in Crohn's disease.
Vermeire S; Louis E; Rutgeerts P; De Vos M; Van Gossum A; Belaiche J; Pescatore P; Fiasse R; Pelckmans P; Vlietinck R; Merlin F; Zouali H; Thomas G; Colombel JF; Hugot JP;
Gastroenterology; 2002 Jul; 123(1):106-11. PubMed ID: 12105838
[TBL] [Abstract][Full Text] [Related]
10. Association of the NOD2 genotype with bacterial translocation via altered cell-cell contacts in Crohn's disease patients.
Kosovac K; Brenmoehl J; Holler E; Falk W; Schoelmerich J; Hausmann M; Rogler G
Inflamm Bowel Dis; 2010 Aug; 16(8):1311-21. PubMed ID: 20232407
[TBL] [Abstract][Full Text] [Related]
11. NOD2 mRNA expression and NFkappaB activation in dogs with lymphocytic plasmacytic colitis.
Okanishi H; Hayashi K; Sakamoto Y; Sano T; Maruyama H; Kagawa Y; Watari T
J Vet Intern Med; 2013; 27(3):439-44. PubMed ID: 23600687
[TBL] [Abstract][Full Text] [Related]
12. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells.
Rosenstiel P; Fantini M; Bräutigam K; Kühbacher T; Waetzig GH; Seegert D; Schreiber S
Gastroenterology; 2003 Apr; 124(4):1001-9. PubMed ID: 12671897
[TBL] [Abstract][Full Text] [Related]
13. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
[TBL] [Abstract][Full Text] [Related]
14. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation.
Gutierrez O; Pipaon C; Inohara N; Fontalba A; Ogura Y; Prosper F; Nunez G; Fernandez-Luna JL
J Biol Chem; 2002 Nov; 277(44):41701-5. PubMed ID: 12194982
[TBL] [Abstract][Full Text] [Related]
15. Nod2 mutation enhances NF-kappa B activity and bacterial killing activity of macrophages.
Tsay TB; Chang CJ; Chen PH; Hsu CM; Chen LW
Inflammation; 2009 Dec; 32(6):372-8. PubMed ID: 19728064
[TBL] [Abstract][Full Text] [Related]
16. Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease.
Thiele K; Bierhaus A; Autschbach F; Hofmann M; Stremmel W; Thiele H; Ziegler R; Nawroth PP
Gut; 1999 Nov; 45(5):693-704. PubMed ID: 10517905
[TBL] [Abstract][Full Text] [Related]
17. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG
Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage.
Tan G; Zeng B; Zhi FC
Eur J Cell Biol; 2015 Jan; 94(1):60-6. PubMed ID: 25433720
[TBL] [Abstract][Full Text] [Related]
19. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
[TBL] [Abstract][Full Text] [Related]
20. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
